Results 141 to 150 of about 27,256 (249)

Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia – a review of its characteristics

Vascular Health and Risk Management, 2015
Wijdan H Ramadan, Wissam K Kabbara Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon Background: The purpose of this study was to review the current literature and information on the combination product ...
Ramadan WH, Kabbara WK
doaj  

Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study [PDF]

, 2021
Ravinder Singh, Harbir Kaur Rao, Anil Kumar Sharma, Thakur Gurjeet Singh, Abhimanyu Parashar, Randhir Singh, Balraj Saini   +6 more
openalex   +1 more source

Sitagliptin Potentiates the Anticancer Activity of Doxorubicin Through ROS-Driven Apoptosis and MMP/TIMP Regulation in HeLa Cells. [PDF]

Pharmaceutics
Güler AE, Tuncer MC, Özdemir İ.
europepmc   +1 more source

Review for "Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects"

, 2021
Thomas Hach
openalex   +1 more source

Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone. [PDF]

Int J Mol Sci
Bogdanov P, Duarri A, Sabater D, Canz MJ, Isla-Magrané H, Ramos H, Deàs-Just A, Simó R, Hernández C.   +8 more
europepmc   +1 more source

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes. A 30-week Randomised, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multi-centre and Multi-national Trial

Novo Nordisk
openalex   +1 more source

Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity

, 2017
Hany M. Abo‐Haded, Mohamed A. Elkablawy, Zeyad Al-johani, Osama Al-ahmadi, Dina S. El‐Agamy   +4 more
openalex   +2 more sources

Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma. [PDF]

BMC Pharmacol Toxicol
Ramalingam PS, Hussain MS, Chellasamy G, Elangovan S, Sharma D, T P, Mishra RAK, Kodiveri Muthukaliannan G, Hussain T, Alrokayan S, Balakrishnan P, Mekala JR, Arumugam S.   +12 more
europepmc   +1 more source

Henoch-Schönlein purpura induced by sitagliptin: A case report. [PDF]

SAGE Open Med Case Rep
Moschella A, Kirshen C.
europepmc   +1 more source

Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). [PDF]

Diabetes Care
Gonzalez JS, Wen H, Butera NM, Uschner D, Krause-Steinrauf H, Gramzinski MR, Wexler DJ, Petrovitch H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Fattaleh B, Lagari V, Walker EA, Cherrington AL, GRADE Research Group* .   +15 more
europepmc   +1 more source